Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity. The SLEEVEPASS randomized clinical trial. JAMA 2018; 319: 241-254.
Published: 5th April 2018
Authors: Salminen P, Helmiö M, Ovaska J, Juuti A, Leivonen M, Peromaa-Haavisto P et al.
Some 217 patients were followed for five years. There was no significant difference in excess body mass index loss in patients who had sleeve gastrectomy (61.1 per cent) versus those who had gastric bypass (68.3 per cent).
You may also be interested in
Efficacy of transversus abdominis plane (TAP) block in pain management after laparoscopic sleeve gastrectomy (LSG): A double-blind randomized controlled trial. Am J Surg 2019; 217: 126-132.
Authors: Saber AA, Lee YC, Arjun C, Namik O, Armand A, Al-Ayoubi S et al.
Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet 2019; 393: 1299-1309.
Authors: Maud R, Espalieu P, Pelascini E, Caiazzo R, Sterkers A, Khamphommala L et al.
Effectiveness of fibrin sealant application on the development of staple line complications after sleeve gastrectomy: a prospective randomized trial. Ann Surg 2018; 268: 762-768.
Authors: Rebibo L, Dhahri A, Chati R, Cosse C, Huet E, Regimbeau J-M et al.
Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity. The SM-BOSS randomized clinical trial. JAMA 2018; 319: 255-265.
Authors: Peterli R, Wölnerhanssen BK, Peters T, Vetter D, Kröll D , Borbély Y et al.
Laparoscopic sleeve gastrectomy versus Roux-Y-gastric bypass for morbid obesity: 3-year outcomes of the prospective randomized Swiss Multicenter Bypass Or Sleeve Study (SM-BOSS). Ann Surg 2017; 265: 466-473.
Authors: Peterli R, Wölnerhanssen BK, Vetter D, Nett P, Gass M, Borbély Y et al.
Standard vs distal Roux-en-Y gastric bypass in patients with body mass index 50 to 60. A double-blind, randomized clinical trial. JAMA Surg 2016; 151: 1146-1155.
Authors: Risstad H, Svanevik M, Kristinsson JA, Hjelmesæth J, Aasheim T, Hofsø D et al.
Impact of surgical technique on long-term complication rate after laparoscopic adjustable gastric banding (LAGB): results of a single-blinded randomized controlled trial (ANOSEAN Study). Ann Surg 2016; 264: 738-744.
Authors: Le Coq B, Frering V, Ghunaim M, Campan P, Dabrowski A, Mulliez E et al.
Closure of mesenteric defects in laparoscopic gastric bypass: a multicentre, randomised, parallel, open-label trial. Lancet 2016; 387: 1397–1404.
Authors: Stenberg E, Szabo E, Ågren G, Ottosson J, Marsk R, Lönroth H et al.
Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment. A randomized clinical trial. JAMA Surg 2015; 150: 931-940.
Authors: Courcoulas AP, Belle SH, Neiberg RH, Pierson SK, Eagleton JK, Kalarchian MA et al. et al.
Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 2015; 386: 964–973.
Authors: Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Nanni G et al. et al.
A prospective randomized multicentre trial of Surgisis Gold, a biologic prosthetic, as a sublay reinforcement of the fascial closure after open bariatric surgery. Surgery 2014; 156: 902-909.
Authors: Sarr MG, Hutcher NE, Snyder S, Hodde J, Carmody B
The effect of the endoscopic duodenal-jejunal bypass liner on obesity and Type 2 diabetes mellitus, a multicenter randomized controlled trial. Ann Surg 2014; 260: 984-992.
Authors: Koehestanie P, de Jonge C, Berends FJ, Janssen IM, Bouvy ND, Greve JW et al.